Join us at our SCOPE Europe Drinks Reception in Barcelona tomorrow evening! Meet the Cytel team and continue the conversations that matter most. Space is limited — please register early to secure your place. hubs.ly/Q04zSFkj0 We hope to see you there!

Independent physician review is the cornerstone of endpoint adjudication, but much of an Endpoint Adjudication Committee's efficiency and effectiveness is determined long before before a physician ever opens a case. Learn more: hubs.ly/Q04zz3yg0

Cytel will be at SCOPE Europe! Our team is ready to help you bring greater visibility and predictability to your next clinical trial through connected trial design and clinical data oversight. Book your meeting today: hubs.ly/Q04zl9FK0 We hope to see you there!

How do you build an FSP workforce that controls costs without compromising quality, capability, or delivery? Join our experts for a webinar that explores how smarter workforce models can strengthen delivery, optimize resources, and create lasting value: hubs.ly/Q04z8JVD0

Next week, the Cytel team will be in Denver at the 2026 CDISC US Interchange!   Stop by and say hello to our team at Booth 6.   See you in Denver! hubs.ly/Q04yHknc0

How do you build an FSP workforce that controls costs without compromising quality, capability, or delivery? Join our experts for a webinar that explores how smarter workforce models can strengthen delivery, optimize resources, and create lasting value: hubs.ly/Q04y0Ndq0

Cytel will be at SCOPE Europe! Our team is ready to help you bring greater visibility and predictability to your next clinical trial through connected trial design and clinical data oversight. Book your meeting today: hubs.ly/Q04yj8_m0 We hope to see you there!

Workforce planning is often approached through the immediate needs of a role. But this can overlook something more fundamental. We discuss the broader questions sponsors should be asking to build teams that can continue to deliver well into the future. hubs.ly/Q04ybTWd0

Parkinson’s disease is the second-most common neurodegenerative disease affecting over 11 million people globally. We discuss common endpoints used in clinical trials with an illustrative case study on how those endpoints may be analyzed. hubs.ly/Q04ybT_L0

NICE has published its AI Delivery Plan. Dalia Dawoud and Manuel Cossio discuss what HTA, HEOR, and market access professionals need to know and how sponsors can prepare as NICE's vision moves from experimentation to implementation. hubs.ly/Q04y5PyW0

In the fight against rare diseases, data is our most precious resource — and greatest challenge. We discuss how, through a case study on IOPD, propensity score methods can be used to estimate treatment effectiveness in this rare disease setting. hubs.ly/Q04y5P-K0

How do you build an FSP workforce that controls costs without compromising quality, capability, or delivery? Join our experts for a webinar that explores how smarter workforce models can strengthen delivery, optimize resources, and create lasting value: hubs.ly/Q04y0N220

On September 24, join Manuel Cossio and Nicolas Rouillé as they explore the applications delivering tangible impact across biometrics and R&D, from data management and document automation to statistical programming. Register today! hubs.ly/Q04vzQ900

For sponsors planning umbrella, basket, or platform trials, recent FDA guidance has shifted the conversation toward what is required to ensure they are sufficiently rigorous for regulatory decision-making. We share what sponsors need to consider: hubs.ly/Q04vtZ7B0

The first EU JCA reports are beginning to highlight what teams need to consider as they prepare for JCA and subsequent national market access. On September 17, join Cytel experts as they discuss practical insights from early JCA experience. Register now! hubs.ly/Q04vqhGV0

Cytel will be at the 2026 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop event in Rockville, Maryland! 📍 Our experts will be at Table 5. Stop by and say hello! Book a meeting: hubs.ly/Q04vkFV_0 See you in Rockville!

Cytel will be at DPHARM in Boston! 📍 Stop by Booth #518 to meet our experts! Don't miss our presentation by Manuel Cossio, Head of AI Solutions. Engineering Token Efficient AI for Clinical Development September 15, 11:35AM See you in Boston! hubs.ly/Q04tYxgC0

FDA's June 2026 draft guidance, Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products, raises critical questions for sponsors.   On September 10, Cytel experts will examine the guidance in detail.   Register today! hubs.ly/Q04tQt8K0

On September 3, Cytel experts will share practical experiences and lessons learned from a recent vaccine submission preparation, drawing on three years of retrospective CBER feedback. Register today! hubs.ly/Q04sJYb-0

As AI becomes integrated into evidence synthesis and EU JCA workflows, evaluation should increasingly measure regulatory fluency — the ability to preserve scientific intent, methodological reasoning, and regulatory context across languages. bit.ly/4fF1k8F